Very good paper. Thank you. Make aways: 1) known and applied for 35 years 2) leads faster to useful results 3) USA and Europe open these trials 4) planning sophisticated 5) evaluation a real science and tricky 6) need good will from regulators
I am sure this is a NO GO for small biotecs like cydy. That's the reason they were talking constantly with FAUCI clan. The evaluation is in no way done in just days or few weeks. This is a difficult task if FDA would be objective which I believe they are not. If they get any EUA within 2 months then we have the confirmation that all is a foolish and corrupted game.